Skip to main content
Clinical Trials/NCT02069275
NCT02069275UnknownNot Applicable

Patients Immediate Mobilization After Coronary Angiography and Percutaneous Coronary Intervention. Is it SAfe to MObilize Patients Very eARly After Cardiac Catheterisation?

Rigshospitalet, Denmark1 site in 1 country2,000 target enrollmentStarted: April 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
2,000
Locations
1
Primary Endpoint
Hematoma> 5 cm

Study Overview

Brief Summary

The purpose of this study is to investigate the frequency of bleeding and haematomas in patients undergoing coronary angiography or percutaneous coronary intervention via femoral artery and mobilized immediately after the procedure, compared to those mobilized after two hours (following the standard regimen). At the same time the investigators will investigate whether it reduces the discomfort being mobilized immediately after the procedure.

Detailed Description

The frequency of hematoma, bleeding or pseudoaneurysm at the access site in the groin is 7-15% with regimens that involve 0-2 hours of bed rest, somewhat more frequent after Percutaneous coronary intervention (PCI) than coronary angiography (CAG). There seems to be no reduction in the complications of the CAG or PCI by maintaining the bed rest for more than 2 hours after the procedure. Angio-Seal seems most effective of current closure devices. There is less discomfort associated with early compared with late mobilization. Protamine reverse heparin's effect without the side effects of that regime.

There lacks a larger randomized study of the safety of mobilizing patients immediately after CAG and after PCI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •CAG or PCI performed via the femoral artery
  • •No hematoma in the groin (> 5 cm in diameter)
  • •Heparin reversed with protamine after PCI

Exclusion Criteria

  • •Oozing, bleeding or hematoma
  • •Treatment with Integrilin, ReoPro, or Marevan
  • •Heparin can not be reversed
  • •The patient does not want to participate
  • •Systolic blood pressure > 180 mm Hg after the procedure
  • •BMI> 35 (can be modified if the groin can be assessed in an upright position)
  • •Demented, unconscious patients who do not understand the information for participants.

Arms & Interventions

Immediate mobilization

Experimental

Immediate mobilization after coronary angiography or percutaneous coronary intervention

Intervention: Immediate mobilization (Other)

Two hours bedrest

Active Comparator

Bedrest two hours after coronary angiography or percutaneous coronary intervention

Intervention: Two hours bedrest (Other)

Outcomes

Primary Outcomes

Hematoma> 5 cm

Time Frame: participants will be followed for the duration of hospital stay, an expected average of 24 hours

occurred after the end of the procedure, including retroperitoneal hematoma, bleeding requiring transfusion or pseudoaneurysm that require vascular surgical intervention. Assessed after 30 minutes, after two hours and before discharge

Secondary Outcomes

  • Comfort rating (NRS scale)(Two hours after the procedure)
  • The presence of hematoma> 10 cm in diameter(participants will be followed for the duration of hospital stay, an expected average of 24 hours)
  • The presence of hematoma 2-5 cm in diameter(participants will be followed for the duration of hospital stay, an expected average of 24 hours)
  • Oozing or bleeding from the puncture site(participants will be followed for the duration of hospital stay, an expected average of 24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marianne Wetendorff Noergaard

Clinical Nurse Specialist

Rigshospitalet, Denmark

Study Sites (1)

Loading locations...

Similar Trials